Your session is about to expire
← Back to Search
Behavioral Intervention
PBT-EF for Obesity and ADHD (FRESH-EF Trial)
N/A
Recruiting
Led By Dawn M Eichen, PhD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at an average of 5 months and 8 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a new program that helps parents teach their overweight or obese children with ADHD how to manage their weight and improve their behavior. The program includes special training to help kids focus better and control their impulses. The goal is to make it easier for these children to stick to healthy habits. Parents focused CBT can be considered as a complementary treatment for reducing ADHD symptoms and BMI and increased self-esteem in the obese ADHD children.
Who is the study for?
This trial is for parents who can read and understand English at a fifth-grade level or higher, with children aged 8-12 diagnosed with ADHD and are overweight (85-99.9% BMI for age). They must be able to attend remote sessions via Zoom. Families already in weight control programs or using weight loss meds, and those with certain medical/psychiatric conditions cannot join.
What is being tested?
The study tests a new treatment program called PBT-EF designed for children with both obesity and ADHD. It's an open-label pilot study where all participants receive the same intervention through remote sessions to improve parental support and child's executive function.
What are the potential side effects?
Since this is a behavioral treatment focusing on education and support without medication, no direct side effects like those from drugs are expected. However, stress or discomfort due to lifestyle changes may occur.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline at an average of 5 months and 8 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at an average of 5 months and 8 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Acceptability
Feasibility as measured by number of treatment sessions attended
Other study objectives
Child behavioral symptoms - Child Behavior Checklist (CBCL)
Child behavioral symptoms - Vanderbilt ADHD [Attention Deficit Hyperactivity Disorder] Parent Rating Scale
Child body mass index (BMI)
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Executive Function-Enhanced Parent-Based Behavioral Treatment (PBT-EF)Experimental Treatment1 Intervention
PBT-EF will integrate executive function training with family-based behavioral treatment (FBT) for obesity, the gold-standard behavioral treatment for childhood obesity. PBT-EF will include self-monitoring, calorie reduction, and dietary and physical activity recommendations in addition to planning, organization, and problem-solving skills.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Behavioral modification and executive function training are common treatments for ADHD that focus on changing maladaptive behaviors and improving cognitive processes. Behavioral modification uses reinforcement strategies to provide clear guidelines and consistent feedback, helping patients improve self-regulation and reduce symptoms.
Executive function training targets skills like working memory, flexible thinking, and self-control, enabling patients to better manage their attention and impulses. These treatments are essential as they address the core deficits in ADHD, offering patients practical tools to manage their symptoms more effectively.
Bibliotherapy as an adjunct to stimulant medication in the treatment of attention-deficit hyperactivity disorder.Behavioural treatment recommendations in clinical practice guidelines for attention-deficit/hyperactivity disorder: a scoping review.
Bibliotherapy as an adjunct to stimulant medication in the treatment of attention-deficit hyperactivity disorder.Behavioural treatment recommendations in clinical practice guidelines for attention-deficit/hyperactivity disorder: a scoping review.
Find a Location
Who is running the clinical trial?
University of California, San DiegoLead Sponsor
1,187 Previous Clinical Trials
1,576,745 Total Patients Enrolled
1 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
144 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Rady Children's Hospital, San DiegoOTHER
41 Previous Clinical Trials
14,203 Total Patients Enrolled
Dawn M Eichen, PhDPrincipal InvestigatorUniversity of California, San Diego
1 Previous Clinical Trials
39 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Children with ADHD are not eligible to participate.The child has a BMI (body mass index) that puts them in the 85-99.9 percentile for their age and is considered overweight or obese.Children who are taking medication for weight loss are not allowed to participate.You have a medical or mental condition that could affect your ability to participate in the treatment or require close monitoring by a doctor, such as serious depression, drug addiction, or psychosis. This applies to both parents and children.You have changed your medication for mental or attention issues within the past three months, and it may impact your weight or ADHD symptoms.
Research Study Groups:
This trial has the following groups:- Group 1: Executive Function-Enhanced Parent-Based Behavioral Treatment (PBT-EF)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.